| Jonathan M Farrell-higgins, PHD | |
|
3649 Sw Burlingame Rd, Topeka, KS 66611-2051 | |
| (785) 266-6751 | |
| (785) 266-4533 |
| Full Name | Jonathan M Farrell-higgins |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 36 Years |
| Location | 3649 Sw Burlingame Rd, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033182001 | NPI | - | NPPES |
| 6146450 | Other | KS | UNITED BEHAVIORAL HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 740 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan M Farrell-higgins, PHD 3649 Sw Burlingame Rd, Topeka, KS 66611-2051 Ph: (785) 266-6751 | Jonathan M Farrell-higgins, PHD 3649 Sw Burlingame Rd, Topeka, KS 66611-2051 Ph: (785) 266-6751 |
News Archive
AVEO Pharmaceuticals, Inc., today announced data from the final analysis of its Phase 2 randomized discontinuation trial evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with advanced renal cell carcinoma.
A surprising finding by Rockefeller University scientists about a rare liver cancer's behavior could lead to more comprehensive patient monitoring and hopefully better outcomes.
In encouraging new study results researchers say that modern treatments have significantly boosted the 15-year survival rate for breast cancer, and even better news is that they have also found that drug and hormonal therapies effectively cure many women, rather than simply delaying the recurrence of disease.
In response to today's Perspective pieces published in the New England Journal Of Medicine, the National Bone Health Alliance (NBHA), a public-private partnership bringing together the expertise and resources of its 42 members from the private and non-profit sectors to collectively advance bone health and prevent disease, commends the U.S. Food and Drug Administration (FDA) for continuing to investigate the risks and benefits of long-term bisphosphonate treatment.
Most physicians are treating the symptom of headache using medication. Patients often receive temporary relief from the medication but it does not deal with the cause of the headache. The drug companies are sponsoring research programs to test their drugs in conjunction with most "Headache Facilities."
› Verified 8 days ago
Dr. Richard M Shapiro, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 225 Sw Greenwood Ave, Topeka, KS 66606 Phone: 785-235-2011 Fax: 785-235-1989 | |
Milfred Douglas Dale, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 2201 Sw 29th Street, Topeka, KS 66611 Phone: 785-267-0025 Fax: 785-266-6546 | |
Joycelyn Parish, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2930 Sw Wanamaker Dr, Topeka, KS 66614 Phone: 785-861-7261 | |
Dr. Judith Corkum, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 835 Sw Western Ave, Topeka, KS 66606 Phone: 785-233-9400 Fax: 785-233-9090 | |
Dr. Kathie Sue Nichols, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3707 Sw 6th Ave, Topeka, KS 66606 Phone: 785-270-4630 Fax: 785-270-4628 | |
Mary Ann Abbott, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2914 Sw Plass Ct, Topeka, KS 66611 Phone: 785-233-7138 Fax: 785-233-7089 | |
Dr. Robert Arlyn Harms, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1911 Sw Gage Blvd, Topeka, KS 66604 Phone: 785-228-1635 |